Basic info
Industry
biotechnology research
Sectors
Biotechnology
Pharmaceutical
specialty chemicals
scale-up
synthetic biology
fermentation
natural products
IP consulting
sustainability
Agritech
Pharma
natural product chemistry
Therapeutics
peptides
microbial strains
tech transfer
strain bioengineering
process development
proteins
CRO
biotech
Date founded
2012
Funding rounds raised
I
Isomerase Therapeutics Ltd. raised undisclosed on August 15, 2016
Investors: Abliva AB